The inhalation-based vaccine showed to be equally as effective as currently used COVID-19 vaccinations, at fractions of the current dose. Researchers from McMaster University have demonstrated that an inhalation-based COVID-19
At the time of the analysis, 7.3% of molnupiravir-treated patients were hospitalized or died by Day 29, compared to 14.1% of placebo-treated patients who were hospitalized or died in the
According to a new study, people who were previously infected with SARS-CoV-2 showed a substantial decrease in cognitive function, with those being hospitalized showing a 7-point decrease in IQ, on
After six to eight months, 26% indicated they felt they hadn’t fully recovered from COVID-19. Furthermore, 55% of participants said they were abnormally fatigued, 25% said they experienced mild difficulty
Patients with SARS-CoV-2 infection had considerably lower levels of 25(OH)D (activated vitamin D) than those who were not infected, according to the study. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is
Researchers determined that ivermectin had no significant impact on preventing COVID-19 patients from being admitted to the hospital in a recent study presenting the findings of a randomized-controlled trial. Since
